 Nicole Tartaglia
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Klinefelter Syndrome | 16 | 2025 | 65 | 6.230 |
Why?
| | Trisomy | 19 | 2023 | 80 | 4.270 |
Why?
| | Sex Chromosome Aberrations | 19 | 2023 | 64 | 3.570 |
Why?
| | Sex Chromosomes | 18 | 2022 | 50 | 2.750 |
Why?
| | Sex Chromosome Disorders of Sex Development | 6 | 2023 | 16 | 2.610 |
Why?
| | Aneuploidy | 12 | 2022 | 89 | 2.500 |
Why?
| | Sex Chromosome Disorders | 8 | 2023 | 23 | 2.190 |
Why?
| | Autism Spectrum Disorder | 7 | 2022 | 395 | 1.770 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 9 | 2022 | 413 | 1.650 |
Why?
| | XYY Karyotype | 10 | 2022 | 22 | 1.620 |
Why?
| | Fragile X Syndrome | 14 | 2022 | 77 | 1.610 |
Why?
| | Chromosomes, Human, X | 12 | 2023 | 73 | 1.580 |
Why?
| | Prenatal Diagnosis | 7 | 2023 | 201 | 1.350 |
Why?
| | Testosterone | 3 | 2025 | 409 | 1.120 |
Why?
| | Child Development | 2 | 2025 | 475 | 0.960 |
Why?
| | Neurodevelopmental Disorders | 2 | 2025 | 181 | 0.930 |
Why?
| | Developmental Disabilities | 5 | 2016 | 263 | 0.810 |
Why?
| | Child | 44 | 2022 | 21935 | 0.810 |
Why?
| | Phenotype | 12 | 2016 | 3196 | 0.740 |
Why?
| | Cognition Disorders | 5 | 2021 | 496 | 0.690 |
Why?
| | Chromosomes, Human, Y | 3 | 2009 | 24 | 0.680 |
Why?
| | Child, Preschool | 30 | 2023 | 11074 | 0.670 |
Why?
| | Ovarian Reserve | 1 | 2020 | 16 | 0.670 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2020 | 38 | 0.660 |
Why?
| | Genetic Association Studies | 2 | 2021 | 377 | 0.610 |
Why?
| | Motor Skills Disorders | 1 | 2018 | 28 | 0.590 |
Why?
| | Neuropsychological Tests | 12 | 2022 | 1023 | 0.590 |
Why?
| | Turner Syndrome | 1 | 2019 | 54 | 0.580 |
Why?
| | Adolescent | 28 | 2022 | 21513 | 0.570 |
Why?
| | Child Behavior | 5 | 2017 | 248 | 0.570 |
Why?
| | Truth Disclosure | 2 | 2016 | 48 | 0.570 |
Why?
| | Child Development Disorders, Pervasive | 5 | 2012 | 62 | 0.560 |
Why?
| | Chromosome Disorders | 2 | 2014 | 43 | 0.540 |
Why?
| | Genetic Testing | 4 | 2021 | 460 | 0.520 |
Why?
| | Students | 1 | 2022 | 622 | 0.520 |
Why?
| | Parents | 4 | 2023 | 1347 | 0.510 |
Why?
| | Adaptation, Physiological | 1 | 2020 | 553 | 0.500 |
Why?
| | Infant | 20 | 2025 | 9465 | 0.490 |
Why?
| | Humans | 67 | 2025 | 137585 | 0.490 |
Why?
| | Executive Function | 4 | 2022 | 451 | 0.470 |
Why?
| | Karyotyping | 4 | 2020 | 104 | 0.470 |
Why?
| | Cognition | 8 | 2022 | 1153 | 0.470 |
Why?
| | Male | 47 | 2025 | 67762 | 0.460 |
Why?
| | Young Adult | 14 | 2021 | 13209 | 0.380 |
Why?
| | Language Development Disorders | 3 | 2019 | 41 | 0.370 |
Why?
| | Autistic Disorder | 4 | 2020 | 204 | 0.360 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 1040 | 0.360 |
Why?
| | Parent-Child Relations | 1 | 2014 | 272 | 0.360 |
Why?
| | Adolescent Development | 1 | 2012 | 86 | 0.360 |
Why?
| | Female | 30 | 2025 | 73304 | 0.350 |
Why?
| | Abnormalities, Multiple | 3 | 2012 | 189 | 0.340 |
Why?
| | Tremor | 2 | 2009 | 65 | 0.330 |
Why?
| | Hormone Replacement Therapy | 1 | 2010 | 100 | 0.320 |
Why?
| | Obesity | 2 | 2020 | 2992 | 0.310 |
Why?
| | Emotions | 4 | 2023 | 548 | 0.310 |
Why?
| | Attention | 5 | 2022 | 427 | 0.290 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2111 | 0.280 |
Why?
| | Adolescent Behavior | 2 | 2012 | 530 | 0.270 |
Why?
| | Adult | 21 | 2023 | 37929 | 0.270 |
Why?
| | Fragile X Mental Retardation Protein | 5 | 2022 | 50 | 0.250 |
Why?
| | Genetic Counseling | 3 | 2023 | 77 | 0.250 |
Why?
| | Perceptual Disorders | 2 | 2019 | 23 | 0.240 |
Why?
| | Pregnancy | 4 | 2023 | 6763 | 0.240 |
Why?
| | DiGeorge Syndrome | 2 | 2019 | 32 | 0.230 |
Why?
| | Case-Control Studies | 4 | 2020 | 3556 | 0.230 |
Why?
| | Space Perception | 2 | 2019 | 80 | 0.230 |
Why?
| | Double-Blind Method | 3 | 2025 | 1993 | 0.220 |
Why?
| | Child Behavior Disorders | 3 | 2016 | 144 | 0.220 |
Why?
| | Y Chromosome | 1 | 2023 | 11 | 0.220 |
Why?
| | Comorbidity | 5 | 2022 | 1622 | 0.210 |
Why?
| | Behavior | 2 | 2019 | 90 | 0.210 |
Why?
| | Visual Perception | 2 | 2019 | 160 | 0.210 |
Why?
| | Cell Adhesion Molecules, Neuronal | 2 | 2015 | 41 | 0.210 |
Why?
| | Syndrome | 4 | 2020 | 358 | 0.210 |
Why?
| | Behavioral Symptoms | 2 | 2022 | 42 | 0.210 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2001 | 131 | 0.210 |
Why?
| | Seizures | 4 | 2022 | 426 | 0.200 |
Why?
| | Mitral Valve Prolapse | 1 | 2022 | 9 | 0.200 |
Why?
| | Puberty | 2 | 2016 | 146 | 0.200 |
Why?
| | Social Behavior | 3 | 2022 | 287 | 0.190 |
Why?
| | Social Change | 1 | 2022 | 15 | 0.190 |
Why?
| | Calcium-Binding Proteins | 2 | 2012 | 218 | 0.190 |
Why?
| | Theory of Mind | 1 | 2022 | 13 | 0.180 |
Why?
| | Body Composition | 1 | 2025 | 684 | 0.180 |
Why?
| | Mental Disorders | 2 | 2017 | 1077 | 0.180 |
Why?
| | Food, Formulated | 1 | 2020 | 14 | 0.170 |
Why?
| | Cross-Sectional Studies | 6 | 2022 | 5472 | 0.170 |
Why?
| | Cannabidiol | 1 | 2022 | 119 | 0.170 |
Why?
| | Cyclic AMP | 1 | 2001 | 234 | 0.170 |
Why?
| | Gonadotropins | 1 | 2020 | 40 | 0.170 |
Why?
| | Glutamates | 1 | 2020 | 59 | 0.170 |
Why?
| | Surveys and Questionnaires | 5 | 2022 | 5778 | 0.170 |
Why?
| | Anti-Mullerian Hormone | 1 | 2020 | 57 | 0.160 |
Why?
| | Infant Formula | 1 | 2020 | 75 | 0.160 |
Why?
| | Toilet Training | 1 | 2019 | 4 | 0.160 |
Why?
| | Educational Status | 1 | 2022 | 470 | 0.160 |
Why?
| | Waist Circumference | 1 | 2020 | 143 | 0.160 |
Why?
| | Mathematical Concepts | 1 | 2019 | 31 | 0.160 |
Why?
| | Time Perception | 1 | 2019 | 28 | 0.160 |
Why?
| | Intelligence | 1 | 2020 | 123 | 0.160 |
Why?
| | Irritable Mood | 1 | 2019 | 50 | 0.150 |
Why?
| | Counseling | 1 | 2022 | 391 | 0.150 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 71 | 0.150 |
Why?
| | Infant, Newborn | 2 | 2025 | 6079 | 0.150 |
Why?
| | Problem Behavior | 1 | 2020 | 102 | 0.150 |
Why?
| | Hippocampus | 2 | 2001 | 895 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 146 | 0.150 |
Why?
| | Face | 1 | 2020 | 173 | 0.150 |
Why?
| | Auditory Perception | 1 | 2019 | 112 | 0.150 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 209 | 0.140 |
Why?
| | Synapses | 2 | 2001 | 427 | 0.140 |
Why?
| | Self-Injurious Behavior | 1 | 2019 | 130 | 0.140 |
Why?
| | Triglycerides | 1 | 2020 | 524 | 0.140 |
Why?
| | Mosaicism | 2 | 2016 | 73 | 0.140 |
Why?
| | Aggression | 1 | 2019 | 202 | 0.140 |
Why?
| | Memory, Short-Term | 1 | 2020 | 250 | 0.140 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 194 | 0.140 |
Why?
| | Prader-Willi Syndrome | 1 | 2017 | 31 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 257 | 0.140 |
Why?
| | Oxandrolone | 1 | 2017 | 8 | 0.130 |
Why?
| | Eosinophilic Esophagitis | 1 | 2021 | 325 | 0.130 |
Why?
| | Disability Evaluation | 1 | 2018 | 290 | 0.130 |
Why?
| | Facies | 1 | 2016 | 21 | 0.130 |
Why?
| | Estradiol | 1 | 2020 | 521 | 0.130 |
Why?
| | X Chromosome Inactivation | 1 | 2016 | 25 | 0.130 |
Why?
| | Speech Disorders | 1 | 2016 | 31 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.130 |
Why?
| | Cohort Studies | 3 | 2020 | 5742 | 0.130 |
Why?
| | Follow-Up Studies | 1 | 2025 | 5131 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 580 | 0.130 |
Why?
| | Testis | 1 | 2016 | 151 | 0.120 |
Why?
| | Transcription Factors | 1 | 2023 | 1719 | 0.120 |
Why?
| | Androgens | 1 | 2017 | 187 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2828 | 0.120 |
Why?
| | Physical Examination | 1 | 2016 | 241 | 0.120 |
Why?
| | Registries | 2 | 2020 | 2035 | 0.110 |
Why?
| | Down Syndrome | 2 | 2013 | 496 | 0.110 |
Why?
| | Nerve Tissue Proteins | 3 | 2012 | 596 | 0.110 |
Why?
| | Neuroimaging | 1 | 2016 | 259 | 0.110 |
Why?
| | Muscle Strength | 1 | 2017 | 317 | 0.110 |
Why?
| | Polymorphism, Genetic | 1 | 2016 | 660 | 0.100 |
Why?
| | Trisomy 13 Syndrome | 1 | 2013 | 3 | 0.100 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2013 | 15 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2426 | 0.100 |
Why?
| | Tetrasomy | 1 | 2012 | 2 | 0.100 |
Why?
| | Self Concept | 1 | 2014 | 253 | 0.100 |
Why?
| | Wechsler Scales | 1 | 2012 | 54 | 0.090 |
Why?
| | Body Mass Index | 1 | 2020 | 2389 | 0.090 |
Why?
| | Trinucleotide Repeat Expansion | 2 | 2008 | 29 | 0.090 |
Why?
| | Exons | 1 | 2012 | 355 | 0.090 |
Why?
| | Gene Deletion | 1 | 2012 | 391 | 0.080 |
Why?
| | Hypogonadism | 1 | 2011 | 92 | 0.080 |
Why?
| | Intellectual Disability | 1 | 2012 | 165 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2012 | 547 | 0.080 |
Why?
| | Data Collection | 1 | 2013 | 673 | 0.080 |
Why?
| | Nonlinear Dynamics | 1 | 2010 | 88 | 0.080 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2008 | 128 | 0.080 |
Why?
| | Body Height | 1 | 2010 | 199 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1774 | 0.080 |
Why?
| | Language Disorders | 1 | 2009 | 30 | 0.080 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2008 | 45 | 0.070 |
Why?
| | Prospective Studies | 1 | 2020 | 7604 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1329 | 0.070 |
Why?
| | Chromosome Deletion | 1 | 2008 | 115 | 0.070 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2008 | 76 | 0.070 |
Why?
| | Genotype | 1 | 2012 | 1916 | 0.070 |
Why?
| | Psychomotor Performance | 1 | 2009 | 309 | 0.060 |
Why?
| | Middle Aged | 6 | 2019 | 33479 | 0.060 |
Why?
| | Risk Factors | 1 | 2020 | 10388 | 0.060 |
Why?
| | Vagus Nerve | 2 | 1997 | 86 | 0.060 |
Why?
| | United States | 1 | 2022 | 14841 | 0.060 |
Why?
| | Prevalence | 2 | 2021 | 2734 | 0.050 |
Why?
| | Interleukin-1 | 3 | 1997 | 965 | 0.050 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2003 | 55 | 0.050 |
Why?
| | Gene Duplication | 1 | 2003 | 68 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2531 | 0.050 |
Why?
| | Time Factors | 2 | 2013 | 6828 | 0.050 |
Why?
| | Muscle Hypotonia | 2 | 2013 | 33 | 0.050 |
Why?
| | Gels | 1 | 2022 | 80 | 0.050 |
Why?
| | Mental Status and Dementia Tests | 1 | 2022 | 26 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 3 | 2010 | 317 | 0.050 |
Why?
| | Abnormal Karyotype | 1 | 2021 | 2 | 0.050 |
Why?
| | Synaptotagmins | 1 | 2001 | 21 | 0.050 |
Why?
| | Vocabulary | 1 | 2021 | 38 | 0.040 |
Why?
| | Synaptic Vesicles | 1 | 2001 | 44 | 0.040 |
Why?
| | Anxiety | 2 | 2020 | 1035 | 0.040 |
Why?
| | Mutation | 2 | 2009 | 3958 | 0.040 |
Why?
| | Rats | 5 | 2001 | 5647 | 0.040 |
Why?
| | Risperidone | 1 | 2019 | 30 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1092 | 0.040 |
Why?
| | Long-Term Potentiation | 1 | 2001 | 198 | 0.040 |
Why?
| | Language | 1 | 2022 | 292 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2001 | 500 | 0.040 |
Why?
| | Gene Expression | 1 | 2023 | 1502 | 0.040 |
Why?
| | Adaptation, Psychological | 1 | 2023 | 655 | 0.040 |
Why?
| | Antidepressive Agents | 1 | 2019 | 236 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 643 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1483 | 0.030 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 290 | 0.030 |
Why?
| | Glucose Intolerance | 1 | 2017 | 146 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 216 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2021 | 15657 | 0.030 |
Why?
| | Communication | 1 | 2022 | 879 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2844 | 0.030 |
Why?
| | Animals | 7 | 2017 | 36940 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2021 | 1069 | 0.030 |
Why?
| | Hand Deformities | 1 | 2013 | 1 | 0.030 |
Why?
| | Metformin | 1 | 2017 | 331 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2071 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2017 | 397 | 0.030 |
Why?
| | Megalencephaly | 1 | 2013 | 20 | 0.030 |
Why?
| | Fever | 1 | 1995 | 306 | 0.030 |
Why?
| | Research | 1 | 2016 | 451 | 0.030 |
Why?
| | Brain | 2 | 1995 | 2668 | 0.020 |
Why?
| | Taste | 1 | 1995 | 229 | 0.020 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2012 | 32 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2012 | 117 | 0.020 |
Why?
| | DNA Copy Number Variations | 1 | 2012 | 182 | 0.020 |
Why?
| | Introns | 1 | 2012 | 258 | 0.020 |
Why?
| | Social Class | 1 | 2013 | 282 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 4 | 1999 | 2486 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2012 | 404 | 0.020 |
Why?
| | Short Stature Homeobox Protein | 1 | 2010 | 1 | 0.020 |
Why?
| | Esophagitis | 1 | 2010 | 67 | 0.020 |
Why?
| | Gene Dosage | 1 | 2010 | 140 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2017 | 10811 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2009 | 100 | 0.020 |
Why?
| | Trinucleotide Repeats | 1 | 2008 | 25 | 0.020 |
Why?
| | DNA Repeat Expansion | 1 | 2008 | 10 | 0.020 |
Why?
| | Ataxia | 1 | 2008 | 44 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2008 | 36 | 0.020 |
Why?
| | Fibromyalgia | 1 | 2008 | 52 | 0.020 |
Why?
| | Chromosome Aberrations | 1 | 2008 | 156 | 0.020 |
Why?
| | Physicians | 1 | 2016 | 910 | 0.020 |
Why?
| | Depression | 1 | 2017 | 1397 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 303 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2010 | 264 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1062 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2009 | 297 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2010 | 506 | 0.020 |
Why?
| | Heterozygote | 1 | 2007 | 293 | 0.020 |
Why?
| | Signal Transduction | 1 | 1999 | 5079 | 0.010 |
Why?
| | Vagotomy | 2 | 1995 | 33 | 0.010 |
Why?
| | Quality of Life | 1 | 2016 | 2892 | 0.010 |
Why?
| | Stereotypic Movement Disorder | 1 | 2003 | 8 | 0.010 |
Why?
| | Pedigree | 1 | 2003 | 514 | 0.010 |
Why?
| | Phospholipase C gamma | 1 | 1999 | 29 | 0.010 |
Why?
| | Type C Phospholipases | 1 | 1999 | 74 | 0.010 |
Why?
| | Electrophysiology | 1 | 1999 | 217 | 0.010 |
Why?
| | Hypertension | 1 | 2008 | 1295 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 182 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 304 | 0.010 |
Why?
| | Mass Screening | 1 | 2007 | 1287 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1999 | 366 | 0.010 |
Why?
| | Histocytochemistry | 1 | 1997 | 80 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1999 | 844 | 0.010 |
Why?
| | Saccharin | 1 | 1995 | 6 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 2057 | 0.010 |
Why?
| | Stress, Physiological | 1 | 1995 | 443 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1995 | 1242 | 0.000 |
Why?
| | Aged | 1 | 2008 | 23961 | 0.000 |
Why?
| | Cytokines | 1 | 1995 | 2085 | 0.000 |
Why?
|
|
Tartaglia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|